Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-255-0 | CAS number: 118-48-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1990-02-20 to 1990-03-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 4H-3,1-benzoxazine-2,4(1H)-dione
- EC Number:
- 204-255-0
- EC Name:
- 4H-3,1-benzoxazine-2,4(1H)-dione
- Cas Number:
- 118-48-9
- Molecular formula:
- C8H5NO3
- IUPAC Name:
- 4H-3,1-benzoxazine-2,4(1H)-dione
- Details on test material:
- - Name of test material (as cited in study report): Isatosäureanhydrid (Isatoic anhydride)
- Physical state: solid (powder), beige, brown
- Analytical purity: 99.8%
- Impurities (identity and concentrations): no data
- Lot/batch No.: 05-0617, filling date: 1989-08-14
- Expiration date of the lot/batch: no data
- Stability under test conditions: stability was ensured for at least the study period
- Storage condition of test material: room temperature
No further data.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr . K . Thomae GmbH, D-7950 Biberach, FRG
- Age at study initiation: 8 - 9 weeks
- Weight at study initiation: male animals (mean ± sd) 265 ± 7.6 9, female animals (mean ± sd) 190 ± 3.9 g
- Fasting period before study: no data
- Housing: 5 per cage
- Diet (ad libitum): KLIBA rat/mouse laboratory diet 24-343-4 10 mm pellets, Klingentalmühle AG, CH-4303 Kaiseraugst, Switzerland,
- Water (ad libitum): tap water
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- other: dust aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: mixing with 1wt% Aerosil
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
A dust aerosol was generated by means of a dosing-wheel dust generator (Gericke/BASF). The concentration was adjusted by varying the rotation of the metering disc.
- Exposure apparatus: Head-nose inhalation system INA 20 (glass-steel construction, BASF Aktiengesellschaft)
- Exposure chamber volume: ca. 55 L
- Method of holding animals in test chamber: the animals were restrained in tubes and their snouts projected into the inhalation chamber
- Source and rate of air: 1500 L/h, no further data
- Method of conditioning air: no data
- System of generating particulates/aerosols: dosing-wheel dust generator
- Method of particle size determination: Equipment: Stack Sampler Mark III (Andersen ), Vacuum Compressed Air Pump (Millipore ), Sampling probe (internal diameter 6 .9 mm), Balance: Sartorius M3P and Mettler AE 240, Evaluation unit (IBM-PC with software PGA )
- Treatment of exhaust air: By means of an exhaust air system the pressure ratios in the inhalation system were adjusted in such a way that the amount of exhaust air was about 10% lower (excess pressure). This ensured that the mixture of test substance and air was not diluted with laboratory air in the breathing zones of the animals.
- Temperature, humidity, pressure in air chamber: no data
TEST ATMOSPHERE
- Brief description of analytical method used:
The nominal concentration was calculated from the amount of substance consumed and the air flow.
The inhalation atmosphere concentration was determined gravimetrically (equipment: Mettler AE 240). The preweighed filter was placed into the filtration equipment. By means of a vacuum compressed air pump a volume of the dust aerosol was drawn through the filter. The dust concentration in mg/L was calculated from the difference between the preweight of the filter and the weight of the filter after sampling, with reference to the sample volume of the inhalation atmosphere. The concentration was corrected for the amount of the added excipient.
- Samples taken from breathing zone: yes
VEHICLE
No vehicle, but mixing with 1 wt% of Aerosil in order to achieve a more uniform dust concentration in air.
TEST ATMOSPHERE (if not tabulated)
The particle size analysis of the test group led to the following results:
The MMAD 50% = 3.0 µm (geometrical standard deviation = 3.2 ) was calculated from the results of the particle size analysis.
A respirable dust aerosol fraction that might reach the alveolar region of 81 % was obtained from the results of the particle size analysis. - Duration of exposure:
- 4 h
- Concentrations:
- analytical concentration: 5.3 +/- 0.390 mg/L(mean +/- sd)
nominal concentration: 71 mg/L - No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The body weight of the animals was checked before the beginning of the test, after 7 days and at the end of the observation period. Clinical findings were recorded several times during exposure and at least once on each workday in the observation period. A check for dead animals was made daily.
- Necropsy of survivors performed: yes - Statistics:
- The statistical evaluation of the concentration/effect relationship was carried out on the basis of the binomial test in accordance with tables of the BASF Computer Center.
The calculation of the particle size distribution was carried out in the Department of Toxicology of BASF Aktiengesellschaft on the basis of mathematical methods for evaluating particle measurements (DIN 66141, DIN 66161).
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.3 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: statistical reliability: 99 .9%
- Mortality:
- No deaths occurred until scheduled sacrifice.
- Clinical signs:
- other: During exposure, the following signs were observed (maximum number of affected animals in brackets): irregular respiration (6/10), accelerated respiration (4/10), eyelid closure (10/10), attempts to escape (10/10). During post-observation, the following s
- Body weight:
- The body weight gain of female rats in the test group, compared with a historical control collective, was not affected by the substance over the total observation period. The body weight gain of male rats in the test group, compared with a historical control collective, was slightly retarded in the second week of the observation period. See table below.
- Gross pathology:
- No pathologic findings were noted.
Any other information on results incl. tables
Table: body weight data
mean body weight in [g]
test group: 5 males, 5 females
historical control group: exposure to air
before the study | after 7 days | after 14 days | ||||
male | female | male | female | male | female | |
test group | 265 | 190 | 292 | 207 | 317 | 219 |
control data | 248 | 177 | 286 | 196 | 318 | 211 |
Applicant's summary and conclusion
- Executive summary:
LC50 > 5.3 mg/L/4 h.
Five male and five female Wistar rats were exposed to a dust aerosol of the test substance for 4 hours using a head/nose exposure system, test concentration: 5.3 mg/L. After exposure, the animals were observed for 14 days. Body weight and clinical symptoms were recorded. At the end of the observation period, surviving animals were sacrificed. Both decedents and survivors were subjected to pathological examination.
No deaths occurred. Clinical signs comprised irregular and/or accelerated respiration, eyelid closure, attempts to escape, reddish smear/crusts around the nose, discoloration/contamination of the fur with the test substance and/or urine. All animals were normal at the day after exposure. Body weight gain was within historical control data for females and slightly retarded in males. Pathology revealed no abnormal findings.
The particle size analysis of the test group led to the following results:
The MMAD 50% = 3.0 µm (geometrical standard deviation = 3.2 ) was calculated.
A respirable dust aerosol fraction that might reach the alveolar region of 81 % was obtained.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.